VERTEX PHARMACEUTICALS INC / MA Available-for-sale Securities, Gross Realized Gain (Loss)
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2019-10-31
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gain (loss) for the quarter ending 2019-09-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gain (loss) for the quarter ending 2018-09-30 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month |
|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 |
| 2018-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |